Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal ...

A trick used by beer-brewing yeast is helping to shine a light on a similar survival mechanism in cancer cells.

Recently, Prof. Huang Qing's group from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences studied ...

Novocure GmbH secured U.S. FDA approval for Optune Lua, a wearable device that delivers alternating electric fields or tumor treating fields that kill cancer cells. Indicated for use with PD-1/PD-L1 ...

It also provides new insights into the effect of SVs on tumor cells. This improves the usefulness of SVs as biomarkers to divide patients into risk groups (stratification). In addition, we ...

根据威尔康奈尔医学、纽约长老会医院、纪念斯隆凯特琳癌症中心和其他机构进行的一项多中心研究，与其他变异相比，KRAS基因的常见突变与胰腺导管腺癌 (PDAC)的总生存率提高有关，部分原因是该突变似乎导致侵袭性较小，生物活性较弱。 根据威尔康奈尔医学、纽约长老会医院、纪念斯隆凯特琳癌症中心和其他机构进行的一项多中心研究，与其他变异相比，KRAS基因的常见突变与胰腺导管腺癌 ...

The new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The ...

A new paper from Elham Azizi's lab and collaborators has been accepted for publication in Genome Research, marking a ...

"CAR-T cell therapy was my last chance, but three months after I had it I was cancer-free and I still am. "It's amazing. I wouldn't have been able to celebrate my 25th wedding anniversary or see three ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

A recent study has revealed that chloride flow through channels on the surface of tumor cell lines plays a crucial role in ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...